A new study provides evidence that the pancreas continues to form beta cells even in the setting of long-standing type 1diabetes.

CVD Events Lowered by 60% Years Later for Intensive Group. By following the participants in the DCCT study since it’s conclusion in 1993, it has continued to provide new information. For the first time, intensive treatment of diabetic patients results in a significantly lower risk of heart disease by 57%.

Combination brings back normal blood glucose levels by increasing beta-cell mass.

A New, Long-Acting Insulin Treatment for Diabetes. Denmark’s Novo Nordisk said on Friday the United States Food and Drug Administration (FDA) has approved its long-acting 24 hr. insulin for treatment of diabetes.

Rimonabant, the first in the new drug class of CB1 blockers, was found to improve hemoglobin A1c (HbA1c) levels, reduce lipid levels and blood pressure, and reduce weight and waist size, researchers reported.

Artery walls begin thickening as early as the midteen years in young people with type 1 diabetes.

Patients with type 2 diabetes who take the new incretin mimetic drug exenatide (Byetta) appear to achieve sustained glucose control and progressive weight reduction after 18 months of therapy.

Engaging in regular vigorous physical activity before pregnancy reduces the risk of gestational diabetes mellitus (GDM).

In 2003 alone, nearly 60% of new cases were obese, and an additional 30% were overweight.

Encapsulating islets cells with polyethylene glycol — may soon obviate the need for immunosuppression in islet cell transplantation.